IEQ Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-31,854
Closed -$683K – 2055
2026
Q1
$683K Buy
+31,854
New +$449K ﹤0.01% 1174
2025
Q3
– Sell
-27,948
Closed -$182K – 1902
2025
Q2
$182K Sell
27,948
-9,064
-24% -$62.4K ﹤0.01% 1632
2025
Q1
$294K Buy
+37,012
New +$399K ﹤0.01% 1198

Other funds holding DAWN

IEQ Capital's DAWN Position: Q2 2026 in Review

IEQ Capital sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 31,854 shares — an estimated $683K sold.

IEQ Capital first reported a position in DAWN in Q1 2025 and held it in 3 quarters. The position peaked at $683K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • IEQ Capital reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • IEQ Capital sold 31,854 Day One Biopharmaceuticals shares in Q2 2026, an estimated $683K.
  • IEQ Capital first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 3 quarters.
  • IEQ Capital's Day One Biopharmaceuticals position peaked at $683K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.